RxDoctor Payments Data

Hugo Rodriguez, PA

Physician Assistant · Canoga Park, CANPI 1306004304

Payments from drug & device makers

$2,302in general payments, 2019–2025

Across 107 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$487
  • Pfizer$264
  • Amgen$253
  • Boehringer Ingelheim$187
  • Novo Nordisk$171
  • Boston Scientific$141
  • plus $799 from 12 others

What the payments were for

  • Food & beverage$2,302100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,302 in reported general payments places this provider in the 80th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$25,840
Medicare patients
67
Services billed
408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin77$63,869
EliquisApixaban21$16,855
Synjardy XrEmpagliflozin/Metformin Hcl13$15,614
TrulicityDulaglutide12$14,162
JanuviaSitagliptin Phosphate19$12,003
FarxigaDapagliflozin Propanediol13$9,363
EntrestoSacubitril/Valsartan12$8,112
SynjardyEmpagliflozin/Metformin Hcl11$6,225
JanumetSitagliptin Phos/Metformin Hcl11$5,628
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,228
LumiganBimatoprost12$2,963
Tolterodine Tartrate ErTolterodine Tartrate22$1,778
Albuterol Sulfate HfaAlbuterol Sulfate45$1,596
Wixela InhubFluticasone Propion/Salmeterol14$1,506
Glimepiride116$1,491

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Synjardy, Stiolto Respimat$187$90,935112 claims
MerckJanuvia, Janumet$55$17,63130 claims
PfizerEliquis$264$16,85521 claims
Lilly USA, LLCTrulicity, Olanzapine$112$14,59232 claims
AbbVieLumigan$79$2,96312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Canoga Park

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →